These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 11732557

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Revisions to the requirements applicable to blood, blood components, and source plasma. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Direct final rule.
    Fed Regist; 1999 Aug 19; 64(160):45366-74. PubMed ID: 10558597
    [Abstract] [Full Text] [Related]

  • 3. Revisions to the requirements applicable to blood, blood components, and source plasma; confirmation in part and technical amendment. Food and Drug Administration, HHS. Direct final rule; confirmation in part and technical amendment.
    Fed Regist; 2001 Jan 10; 66(7):1834-7. PubMed ID: 11503754
    [Abstract] [Full Text] [Related]

  • 4. Revisions to the requirements applicable to blood, blood components and source plasma. Direct final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Aug 16; 72(158):45883-88. PubMed ID: 17847577
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human). Food and Drug Administration, HHS. Direct final rule.
    Fed Regist; 1999 May 14; 64(93):26282-7. PubMed ID: 10558530
    [Abstract] [Full Text] [Related]

  • 8. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human); companion document to direct final rule. Food and Drug Administration, HHS. Proposed rule.
    Fed Regist; 1999 May 14; 64(93):26344-8. PubMed ID: 10558531
    [Abstract] [Full Text] [Related]

  • 9. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
    Fed Regist; 1996 Sep 09; 61(175):47413-23. PubMed ID: 10160337
    [Abstract] [Full Text] [Related]

  • 10. Revision to requirements for licensed Anti-Human Globulin and Blood Grouping Reagents. Food and Drug Administration, HHS. Direct final rule.
    Fed Regist; 2000 Dec 12; 65(239):77497-9. PubMed ID: 11503726
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Biological products; blood specificity designators; technical amendments--FDA. Final rule; technical amendments.
    Fed Regist; 1994 May 06; 59(87):23636-7. PubMed ID: 10184096
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Blood and blood components; error and accident reports--Food and Drug Administration. Proposed rule.
    Fed Regist; 1980 Aug 08; 45(155):52821-4. PubMed ID: 10247831
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.